US big company (Cephalon) takeover bid last year at $4.8 prove the credibility of Sirtex liver cancer treatment tech. There is not much competitor on its product either. Only one other company Nordion, is developing similar drug.
At $3 marks, SRX looks cheap. I'm sure Cephalon is watching and may put another offer on the table.
Comments welcome.
I hold lots.